Pneumonectomy

• 

  Subject Areas on Research

  • A Minimally Invasive Approach to Lobectomy After Induction Therapy Does Not Compromise Survival. 
  • A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer. 
  • A National Analysis of Minimally Invasive Vs Open Segmentectomy for Stage IA Non-Small-Cell Lung Cancer. 
  • A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer. 
  • A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. 
  • A cost-minimisation analysis of lobectomy: thoracoscopic versus posterolateral thoracotomy. 
  • A model for morbidity after lung resection in octogenarians. 
  • A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. 
  • A new technique for lung isolation in acute thoracic trauma. 
  • A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531. 
  • A randomised trial of lung sealant versus medical therapy for advanced emphysema. 
  • A stitch (or scan) in time saves nine. 
  • A young male with history of alcohol abuse with opacified left hemithorax and massive hemoptysis. 
  • Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. 
  • Adjuvant Chemotherapy After Lobectomy for T1-2N0 Non-Small Cell Lung Cancer: Are the Guidelines Supported? 
  • Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors. 
  • Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis. 
  • Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. 
  • Alternatives to Lobectomy for High-Risk Patients With Early-Stage Non-Small Cell Lung Cancer. 
  • An inexpensive, reproducible tissue simulator for teaching thoracoscopic lobectomy. 
  • Apneic oxygen insufflation decreases the incidence of hypoxemia during one-lung ventilation in open and thoracoscopic pulmonary lobectomy: A randomized controlled trial. 
  • Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant? 
  • Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients. 
  • Bilateral pneumonectomy with veno-arterial extracorporeal membrane oxygenation as a bridge to lung transplant. 
  • Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503. 
  • Cardiac tamponade complicating trimodal therapy for malignant mesothelioma. 
  • Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer. 
  • Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. 
  • Commentary: Are we home yet? 
  • Commentary: Measures of relevance from relevant measurements: Pulmonary artery size on computed tomography as predictor of postlobectomy complications. 
  • Community Size and Lung Cancer Resection Outcomes: Studying The Society of Thoracic Surgeons Database. 
  • Comparison of performance status with peak oxygen consumption in operable patients with non-small-cell lung cancer. 
  • Complications of thoracoscopic pulmonary resection. 
  • Concentration of 99mTechnetium polyphosphate in fibrothorax following pneumonectomy. 
  • Congenital unilateral pulmonary vein atresia: radiologic findings in three adult patients. 
  • Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. 
  • Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. 
  • Conversion to Thoracotomy During Thoracoscopic vs Robotic Lobectomy: Predictors and Outcomes. 
  • Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data. 
  • Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy. 
  • Defining and improving postoperative care. 
  • Defining the role of adjuvant chemotherapy after lobectomy for typical bronchopulmonary carcinoid tumors. 
  • Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document. 
  • Diagnosis and treatment of stage-III peripheral squamous cell carcinoma of right upper lung. 
  • Differential effects of operative complications on survival after surgery for primary lung cancer. 
  • Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. 
  • Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery. 
  • Does pneumonectomy have a role in the treatment of stage IIIA non-small cell lung cancer? 
  • EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. 
  • Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. 
  • Effect of Lymph Node Assessment on Outcomes in Surgery for Limited Stage Small Cell Lung Cancer. 
  • Effect of Zephyr Endobronchial Valves on Dyspnea, Activity Levels, and Quality of Life at One Year. Results from a Randomized Clinical Trial. 
  • Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. 
  • Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy. 
  • Endobronchial Carcinoid Tumor Totally Occluding the Left Main Bronchus Without Producing Symptoms of Bronchial Obstruction. 
  • Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction. 
  • Esophageal varices in association with unilateral pulmonary vein atresia. 
  • Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy. 
  • Extended surgical staging for potentially resectable malignant pleural mesothelioma. 
  • Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply. 
  • Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. 
  • Factors Associated With New Persistent Opioid Usage After Lung Resection. 
  • Factors Associated With Successful Postoperative Day One Discharge After Anatomic Lung Resection. 
  • Factors affecting selection of operative approach and subsequent short-term outcomes after anatomic resection for lung cancer. 
  • Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection. 
  • Fewer complications result from a video-assisted approach to anatomic resection of clinical stage I lung cancer. 
  • Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection. 
  • Gender Bias Affects Assessment of Frailty and Recommendations for Surgery. 
  • Genetic changes in contralateral bronchioloalveolar carcinomas of the lung. 
  • Geographic Variations in Lung Cancer Lobectomy Outcomes: The General Thoracic Surgery Database. 
  • Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer. 
  • Historical perspectives of The American Association for Thoracic Surgery: Evarts A. Graham (1883-1957). 
  • How I Teach a Thoracoscopic Lobectomy. 
  • Imagine all the people... 
  • Immunotherapy for Resected Pulmonary Metastases. 
  • Impact of Chest Wall Resection on Mortality After Lung Resection for Non-Small Cell Lung Cancer. 
  • Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer. 
  • Impact of Surveillance After Lobectomy for Lung Cancer on Disease Detection and Survival. 
  • Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung cancer. 
  • Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma. 
  • Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer. 
  • Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer. 
  • Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival. 
  • Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer. 
  • Initial and Longitudinal Cost of Surgical Resection for Lung Cancer. 
  • Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. 
  • Intraoperative techniques to prevent air leaks. 
  • Invasive Mediastinal Staging for Lung Cancer by The Society of Thoracic Surgeons Database Participants. 
  • Invited Commentary. 
  • Invited Commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients. 
  • Lack of correlation between short- and long-term performance after lung cancer surgery. 
  • Latest advances in advanced diagnostic and therapeutic pulmonary procedures. 
  • Less is more: a shift in the surgical approach to non-small-cell lung cancer. 
  • Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. 
  • Lobectomy by Video-Assisted Thoracic Surgery or Muscle-Sparing Thoracotomy for Stage 1 Lung Cancer: Could Cost-Effectiveness Give the Answer? 
  • Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. 
  • Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data. 
  • Location of the Tumor is a "Central" Predictor of Nodal (N1) Upstaging. 
  • Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. 
  • Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer. 
  • Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis. 
  • Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis. 
  • Long-term outcomes of thoracoscopic lobectomy. 
  • Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer. 
  • Longitudinal Follow-up of Lung Cancer Resection From the Society of Thoracic Surgeons General Thoracic Surgery Database in Patients 65 Years and Older. 
  • Low morbidity and mortality for bronchoplastic procedures with and without induction therapy. 
  • Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. 
  • Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. 
  • Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy. 
  • Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. 
  • Meta-analysis and Systematic Review of Bronchoscopic Lung Volume Reduction Through Endobronchial Valves in Severe Emphysema. 
  • Minimally Invasive Approaches Do Not Compromise Outcomes for Pneumonectomy: A Comparison Using the National Cancer Database. 
  • Modern Management of Pulmonary Metastases. 
  • Modified uniportal video-assisted thoracoscopic lobectomy: Duke approach. 
  • National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. 
  • Needs assessment for an errors-based curriculum on thoracoscopic lobectomy. 
  • No heroic measures: how soon is too soon to stop? 
  • Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. 
  • Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. 
  • Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments. 
  • Operative techniques in early-stage lung cancer. 
  • Outcomes after pneumonectomy for benign disease: the impact of urgent resection. 
  • Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. 
  • Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients. 
  • Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer. 
  • Pancreatoblastoma in a teenage patient. 
  • Paravertebral block: the first procedure with "no contraindications" … really? 
  • Pathologic response rates following definitive dose image-guided chemoradiotherapy and resection for locally advanced non-small cell lung cancer. 
  • Patterns of Failure After Surgery for Non-Small-cell Lung Cancer Invading the Chest Wall. 
  • Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer. 
  • Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. 
  • Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons General Thoracic Surgery Database for Lobectomy. 
  • Perioperative Outcomes and 5-year Survival After Open versus Thoracoscopic Sleeve Resection for Lung Cancer. 
  • Perioperative Outcomes and Survival After Preoperative Immunotherapy for Non-Small Cell Lung Cancer. 
  • Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. 
  • Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). 
  • Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer. 
  • Phase II study of neoadjuvant chemotherapy and radiation therapy with thoracotomy in the treatment of clinically staged IIIA non-small cell lung cancer. 
  • Plasticity of Hopx(+) type I alveolar cells to regenerate type II cells in the lung. 
  • Prediction of Long-Term Survival After Lung Cancer Surgery for Elderly Patients in The Society of Thoracic Surgeons General Thoracic Surgery Database. 
  • Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema. 
  • Predictors of prolonged length of stay after lobectomy for lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk-adjustment model. 
  • Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. 
  • Prevention of acute exacerbation of chronic obstructive pulmonary disease after bronchoscopic lung volume reduction with endobronchial valves. 
  • Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. 
  • Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection. 
  • Pulmonary Granular Cell Tumors: A Study of 4 Cases Including a Malignant Phenotype. 
  • Pulmonary Open, Robotic, and Thoracoscopic Lobectomy (PORTaL) Study: An Analysis of 5721 Cases. 
  • Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. 
  • Pulmonary rehabilitation in the surgical patient. Lung transplantation and lung volume reduction surgery. 
  • Pulmonary rehabilitation of the patient with nonobstructive lung disease. 
  • Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. 
  • Pulmonary venous infarction after radiofrequency ablation for atrial fibrillation. 
  • Quality of life and survival after II stage nonsmall cell carcinoma surgery: Video-assisted thoracic surgery versus thoracotomy lobectomy. 
  • Quality of life outcomes are equivalent after lobectomy in the elderly. 
  • Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis. 
  • Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations. 
  • Racial disparities among patients with lung cancer who were recommended operative therapy. 
  • Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment. 
  • Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group. 
  • Readmission After Lobectomy for Lung Cancer: Not All Complications Contribute Equally. 
  • Reply: To PMID 23545195. 
  • Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. 
  • Response to Comment on "A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmall-cell Lung Cancer". 
  • Response. 
  • Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer. 
  • Risk calculators are useful but.... 
  • Risk factors for atrial fibrillation after lung cancer surgery: analysis of the Society of Thoracic Surgeons general thoracic surgery database. 
  • Risk factors for morbidity after lobectomy for lung cancer in elderly patients. 
  • Risk of Each of the Five Lung Lobectomies: A Society of Thoracic Surgeons Database Analysis. 
  • Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. 
  • STS database risk models: predictors of mortality and major morbidity for lung cancer resection. 
  • Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. 
  • Segmentectomy and Lung Cancer: Why, When, How, and How Good? 
  • Self-perceived video-assisted thoracic surgery lobectomy proficiency by recent graduates of North American thoracic residencies. 
  • Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection. 
  • Simultaneous thigh muscle metastasis from lung cancer and Escherichia coli gas producing myonecrosis. 
  • Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival. 
  • Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis. 
  • Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. 
  • State of the Art: Interventional Pulmonology. 
  • Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. 
  • Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. 
  • Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. 
  • Successful use of hypnosis as an adjunctive therapy for weaning from mechanical ventilation. 
  • Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer. 
  • Surgery versus stereotactic body radiation therapy for operable stage I non-small cell lung cancer: Can we achieve equipoise? 
  • Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. 
  • Surgical Evaluation in Patients Undergoing Radiation Therapy for Early-Stage Lung Cancer. 
  • Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer. 
  • Surgical management of pulmonary metastases. 
  • Surgical techniques to avoid parenchymal injury during lung resection (fissureless lobectomy). 
  • Surgically Managed Clinical Stage IIIA-Clinical N2 Lung Cancer in The Society of Thoracic Surgeons Database. 
  • Survival after radiation for stage I and II non-small cell lung cancer with positive margins. 
  • Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management. 
  • Synchronous resection of esophageal cancer and other organ malignancies: A systematic review. 
  • Technique of thoracoscopic basilar segmentectomy. 
  • Temporal trends in the management of potentially resectable lung cancer. 
  • The Effect of Tumor Size and Histologic Findings on Outcomes After Segmentectomy vs Lobectomy for Clinically Node-Negative Non-Small Cell Lung Cancer. 
  • The Oldest Old: A National Analysis of Outcomes for Patients 90 Years or Older With Lung Cancer. 
  • The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients. 
  • The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer. 
  • The Society of Thoracic Surgeons Composite Score for Rating Program Performance for Lobectomy for Lung Cancer. 
  • The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes. 
  • The best that surgery has to offer. 
  • The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies. 
  • The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer. 
  • The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. 
  • The impact of pre-radiotherapy surgery on radiation-induced lung injury. 
  • The impact of pulmonary hypertension on morbidity and mortality following major lung resection. 
  • The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study. 
  • The surgical management of lung cancer. 
  • Thoracoscopic Lobectomy for Non-small Cell Lung Cancer. 
  • Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy. 
  • Thoracoscopic lobectomy facilitates the delivery of chemotherapy after resection for lung cancer. 
  • Thoracoscopic lobectomy for the management of non-small cell lung cancer. 
  • Thoracoscopic lobectomy has increasing benefit in patients with poor pulmonary function: a Society of Thoracic Surgeons Database analysis. 
  • Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. 
  • Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal. 
  • Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. 
  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. 
  • Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. 
  • Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. 
  • Thoracoscopic lobectomy: evolving and improving. 
  • Thoracoscopic lobectomy: the gold standard for early-stage lung cancer? 
  • Thoracoscopic pneumonectomy in management of histoplasmosis and fibrosing mediastinitis. 
  • Thoracoscopic segmentectomy for lung cancer. 
  • Thoracoscopic segmentectomy: technical considerations and outcomes. 
  • Thoracoscopic versus robotic approaches: advantages and disadvantages. 
  • Tough problem, creative solution. 
  • Tumor Size, Histology, and Survival After Stereotactic Ablative Radiotherapy and Sublobar Resection in Node-negative Non-small Cell Lung Cancer. 
  • Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. 
  • Uniportal video-assisted thoracic surgery: a call for better evidence, not just more evidence. 
  • Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. 
  • VATS and Minimally Invasive Resection in Early-Stage NSCLC. 
  • VATS lobectomy has better perioperative outcomes than open lobectomy: CALGB 31001, an ancillary analysis of CALGB 140202 (Alliance). 
  • VATS versus open surgery for lung cancer resection: moving toward a minimally invasive approach. 
  • Variability in Smoking Status for Lobectomy Among Society of Thoracic Surgeons Database Participants. 
  • Variability in the treatment of elderly patients with stage IIIA (N2) non-small-cell lung cancer. 
  • Video-assisted thoracic surgery in the elderly. A review of 307 cases. 
  • Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. 
  • Video-assisted thoracoscopic surgery lobectomy at 20 years: a consensus statement. 
  • Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer. 
  • Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: the Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. 
  • eComment. The role of local recurrence in the development of post-resectional bronchopleural fistula. 
• 

  Keywords of People

  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology